Didanosine

SKU: orb1305302

Description

Didanosine

Research Area

Infectious Disease & Virology, Protein Biochemistry

Key Properties

• CAS Number: 69655-05-6
• MW: 236.23
• Purity: 99.81%
• Formula: C₁₀H₁₂N₄O₃
• SMILES: O=C1C2=C(N(C=N2)[C@@H]3O[C@H](CO)CC3)NC=N1
• Target: Reverse Transcriptase,HIV Protease
• Solubility: H2O:< 1 mg/mL (insoluble or slightly soluble);Ethanol:< 1 mg/mL (insoluble or slightly soluble);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (8.47 mM);DMSO:70 mg/mL (296.32 mM)

Bioactivity

• Target IC50:
  Reverse transcriptase:0.49 μM
• In Vivo:
  In cultured human muscle cells, Didanosine induced accumulation of cytoplasmic lipid droplets, increased lactate production, and decreased SDH (part of complex II) and COX (complex IV) activity. In HIV target cells, Didanosine was converted to its active form, deoxyadenosine-5'-triphosphate (ddATP). In dissociated DRG cells in culture, Didanosine dose-dependently induced reductions in the number of neurites, the length of each neurite in the longest neurite, and the total length of the neurite. In dissociated DRG neurons, Didanosine dose-dependently induced neurite retraction or axon loss, suggesting that desipramine is useful in the development of peripheral neuropathy. In cultured human TK6 lymphoblastoid cells, Didanosine induced mutagenicity of the thymidine kinase gene induced by zidovudine.

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

ReverseTranscriptase, Reverse Transcriptase, orally active, inhibit, HIV Protease, HIVProtease, HIV, Inhibitor, Human immunodeficiency virus, IEC-6 cells, ddI, 2',3'-Dideoxyinosine, apoptosis, antiretroviral, Didanosine

Compound Identifiers

PubChem CID

135398739